RecruitingPHASE1, PHASE2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Studying Down syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PedAL BCU, LLC
Principal Investigator
Michele S Redell
Children's Oncology Group
Intervention
Biospecimen Collection(procedure)
Enrollment
960 enrolled
Eligibility
22 years · All sexes
Timeline
20222030

Study locations (30)

Collaborators

Children's Oncology Group · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04726241 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome

← Back to all trials